Protein med evne til a inhibere kollagenstimulert blodplateaggregering og forhindre interaksjoner mellom kollagen og von Willebrands faktor (vWF), fremgangsmate for fremstilling derav, farmasoytisk preparat som omfatter det, medisinsk anordning som er belagt med det, samt anvendelser derav for fremstilling av medikamenter

PCT No. PCT/EP94/02087 Sec. 371 Date Feb. 28, 1995 Sec. 102(e) Date Feb. 28, 1995 PCT Filed Jun. 28, 1994 PCT Pub. No. WO95/01375 PCT Pub. Date Jan. 12, 1995A protein isolated from crude extracts of Hirudo medicinalis is disclosed, which strongly inhibits the binding to collagen of platelets and the...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	MELZER GUIDO, HEMBERGER JUERGEN
Format:	Patent
Sprache:	nor
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	MELZER GUIDO HEMBERGER JUERGEN
description	PCT No. PCT/EP94/02087 Sec. 371 Date Feb. 28, 1995 Sec. 102(e) Date Feb. 28, 1995 PCT Filed Jun. 28, 1994 PCT Pub. No. WO95/01375 PCT Pub. Date Jan. 12, 1995A protein isolated from crude extracts of Hirudo medicinalis is disclosed, which strongly inhibits the binding to collagen of platelets and their subsequent activation, which leads to platelet aggregation and thrombus formation. Additionally the protein prevents binding of von Willebrand factor to collagen. Described is a method for isolation and purification of the protein as well as its use for blocking collagen-stimulated platelet aggregation. The new protein (Brandinin) has a molweight of approximately 15 kD, binds to collagen but has no collagen-cleaving activity. The protein is useful in the prophylaxis, prevention and treatment of thrombotic diseaeses and for coating of blood-contacting materials, rendering them thromboresistant.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_NO320150BB1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>NO320150BB1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_NO320150BB13</originalsourceid><addsrcrecordid>eNqNj7FOAzEMhsvAgIB38AhSkVoqXqAVFRMwIHWsfMSXhkvsk2NO4u1xToiFhSmS8_n7f1-c7V5VjBJDoQA0MYGlDAiJT6kjJRgkZ4zE1VL5zKQGXZYwZjTCGJUiaeIIEqEXPSUOvpPYSHGoH8Kkbs5Zyq-ooZMwHFLO1ClyqNDjYKJwMx32t0volUpEjrV4SNPOEy-Qc4sK7p6cQi1Y5ctSHWBUGlHRoHqSlB7NGzhpy3ZYqokdQhYN3BSN8v-OvJHNp89oxWJOTcSBcp0FHvW3gc-adcBC7dKrxXmPzl__vJcL2D--7Z7uaJQj1RHficmOzy-b-9X6YbXdrjf_QL4BjoKSbA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Protein med evne til a inhibere kollagenstimulert blodplateaggregering og forhindre interaksjoner mellom kollagen og von Willebrands faktor (vWF), fremgangsmate for fremstilling derav, farmasoytisk preparat som omfatter det, medisinsk anordning som er belagt med det, samt anvendelser derav for fremstilling av medikamenter</title><source>esp@cenet</source><creator>MELZER GUIDO ; HEMBERGER JUERGEN</creator><creatorcontrib>MELZER GUIDO ; HEMBERGER JUERGEN</creatorcontrib><description>PCT No. PCT/EP94/02087 Sec. 371 Date Feb. 28, 1995 Sec. 102(e) Date Feb. 28, 1995 PCT Filed Jun. 28, 1994 PCT Pub. No. WO95/01375 PCT Pub. Date Jan. 12, 1995A protein isolated from crude extracts of Hirudo medicinalis is disclosed, which strongly inhibits the binding to collagen of platelets and their subsequent activation, which leads to platelet aggregation and thrombus formation. Additionally the protein prevents binding of von Willebrand factor to collagen. Described is a method for isolation and purification of the protein as well as its use for blocking collagen-stimulated platelet aggregation. The new protein (Brandinin) has a molweight of approximately 15 kD, binds to collagen but has no collagen-cleaving activity. The protein is useful in the prophylaxis, prevention and treatment of thrombotic diseaeses and for coating of blood-contacting materials, rendering them thromboresistant.</description><edition>7</edition><language>nor</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2005</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20051031&DB=EPODOC&CC=NO&NR=320150B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20051031&DB=EPODOC&CC=NO&NR=320150B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MELZER GUIDO</creatorcontrib><creatorcontrib>HEMBERGER JUERGEN</creatorcontrib><title>Protein med evne til a inhibere kollagenstimulert blodplateaggregering og forhindre interaksjoner mellom kollagen og von Willebrands faktor (vWF), fremgangsmate for fremstilling derav, farmasoytisk preparat som omfatter det, medisinsk anordning som er belagt med det, samt anvendelser derav for fremstilling av medikamenter</title><description>PCT No. PCT/EP94/02087 Sec. 371 Date Feb. 28, 1995 Sec. 102(e) Date Feb. 28, 1995 PCT Filed Jun. 28, 1994 PCT Pub. No. WO95/01375 PCT Pub. Date Jan. 12, 1995A protein isolated from crude extracts of Hirudo medicinalis is disclosed, which strongly inhibits the binding to collagen of platelets and their subsequent activation, which leads to platelet aggregation and thrombus formation. Additionally the protein prevents binding of von Willebrand factor to collagen. Described is a method for isolation and purification of the protein as well as its use for blocking collagen-stimulated platelet aggregation. The new protein (Brandinin) has a molweight of approximately 15 kD, binds to collagen but has no collagen-cleaving activity. The protein is useful in the prophylaxis, prevention and treatment of thrombotic diseaeses and for coating of blood-contacting materials, rendering them thromboresistant.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2005</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNj7FOAzEMhsvAgIB38AhSkVoqXqAVFRMwIHWsfMSXhkvsk2NO4u1xToiFhSmS8_n7f1-c7V5VjBJDoQA0MYGlDAiJT6kjJRgkZ4zE1VL5zKQGXZYwZjTCGJUiaeIIEqEXPSUOvpPYSHGoH8Kkbs5Zyq-ooZMwHFLO1ClyqNDjYKJwMx32t0volUpEjrV4SNPOEy-Qc4sK7p6cQi1Y5ctSHWBUGlHRoHqSlB7NGzhpy3ZYqokdQhYN3BSN8v-OvJHNp89oxWJOTcSBcp0FHvW3gc-adcBC7dKrxXmPzl__vJcL2D--7Z7uaJQj1RHficmOzy-b-9X6YbXdrjf_QL4BjoKSbA</recordid><startdate>20051031</startdate><enddate>20051031</enddate><creator>MELZER GUIDO</creator><creator>HEMBERGER JUERGEN</creator><scope>EVB</scope></search><sort><creationdate>20051031</creationdate><title>Protein med evne til a inhibere kollagenstimulert blodplateaggregering og forhindre interaksjoner mellom kollagen og von Willebrands faktor (vWF), fremgangsmate for fremstilling derav, farmasoytisk preparat som omfatter det, medisinsk anordning som er belagt med det, samt anvendelser derav for fremstilling av medikamenter</title><author>MELZER GUIDO ; HEMBERGER JUERGEN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_NO320150BB13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>nor</language><creationdate>2005</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>MELZER GUIDO</creatorcontrib><creatorcontrib>HEMBERGER JUERGEN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MELZER GUIDO</au><au>HEMBERGER JUERGEN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Protein med evne til a inhibere kollagenstimulert blodplateaggregering og forhindre interaksjoner mellom kollagen og von Willebrands faktor (vWF), fremgangsmate for fremstilling derav, farmasoytisk preparat som omfatter det, medisinsk anordning som er belagt med det, samt anvendelser derav for fremstilling av medikamenter</title><date>2005-10-31</date><risdate>2005</risdate><abstract>PCT No. PCT/EP94/02087 Sec. 371 Date Feb. 28, 1995 Sec. 102(e) Date Feb. 28, 1995 PCT Filed Jun. 28, 1994 PCT Pub. No. WO95/01375 PCT Pub. Date Jan. 12, 1995A protein isolated from crude extracts of Hirudo medicinalis is disclosed, which strongly inhibits the binding to collagen of platelets and their subsequent activation, which leads to platelet aggregation and thrombus formation. Additionally the protein prevents binding of von Willebrand factor to collagen. Described is a method for isolation and purification of the protein as well as its use for blocking collagen-stimulated platelet aggregation. The new protein (Brandinin) has a molweight of approximately 15 kD, binds to collagen but has no collagen-cleaving activity. The protein is useful in the prophylaxis, prevention and treatment of thrombotic diseaeses and for coating of blood-contacting materials, rendering them thromboresistant.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	nor
recordid	cdi_epo_espacenet_NO320150BB1
source	esp@cenet
subjects	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title	Protein med evne til a inhibere kollagenstimulert blodplateaggregering og forhindre interaksjoner mellom kollagen og von Willebrands faktor (vWF), fremgangsmate for fremstilling derav, farmasoytisk preparat som omfatter det, medisinsk anordning som er belagt med det, samt anvendelser derav for fremstilling av medikamenter
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T14%3A15%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MELZER%20GUIDO&rft.date=2005-10-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ENO320150BB1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true